Mark McDade

Mark McDade

Director/Board Member presso LUPIN LIMITED

Patrimonio netto: 11 862 $ in data 31/03/2024

69 anni
Health Technology
Finance
Commercial Services

Profilo

Mark D.
McDade
is the founder of Corixa Corp.
(founded in 1994) and Qiming US Ventures Management, LLC (founded in 2017).
He is currently working as an Independent Non-Executive Director at Lupin Ltd.
since 2021 and as a Director at UCB Celltech since 2008.
He also holds director positions at Cadent Therapeutics, Inc., Amphivena Therapeutics, Inc., Twine Health, Inc., WindMIL Therapeutics, Inc., Stellular Bio, Inc., Phillips Edison Grocery Center REIT II, Inc., LetsGetChecked, Inc., Soda Health, Inc., and will be an Independent Director at Tourmaline Bio, Inc. starting in 2023.
In the past, he served as the Chief Executive Officer of Protein Design Labs, Inc. from 2002 to 2006, Chief Executive Officer of Signature BioScience, Inc. from 2000 to 2002, Chairman of Aimmune Therapeutics, Inc. from 2014 to 2020, and Director of Valentis, Inc. from 2000 to 2006.
He has also held various director positions at Cytokinetics, Inc., Five Prime Therapeutics, Inc., Phillips Edison-ARC Grocery Center REIT II, Inc., PDL BioPharma, Inc., LigoCyte Pharmaceuticals, Inc., Dermira, Inc., MyHealthTeam, Inc., ZappRx, Inc., Talaris Therapeutics, Inc., Phillips Edison Grocery Center REIT III, Inc., and Icosavax, Inc. He was the Executive Vice President-Established Brands at UCB, Inc. from 2013 onwards.
Mr. McDade completed his undergraduate degree at Dartmouth College in 1977 and earned an MBA from Harvard Business School in 1984.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
0.00%
29/01/2024 518 ( 0.00% ) 11 862 $ 31/03/2024

Posizioni attive di Mark McDade

SocietàPosizioneInizio
LUPIN LIMITED Director/Board Member 28/01/2021
Director/Board Member -
Director/Board Member 01/06/2017
Director/Board Member 01/11/2017
Director/Board Member 27/10/2008
Founder 01/01/2017
Director/Board Member -
Director/Board Member -
Director/Board Member -
Tutte le posizioni attive di Mark McDade

Precedenti posizioni note di Mark McDade

SocietàPosizioneFine
░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Mark McDade

Formazione di Mark McDade

Dartmouth College Undergraduate Degree
Harvard Business School Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark McDade

Relazioni

100 +

Relazioni di 1° grado

34

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
CYTOKINETICS, INCORPORATED

Health Technology

UCB

Health Technology

LUPIN LIMITED

Health Technology

Aziende private29

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

LigoCyte Pharmaceuticals, Inc.

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Technology Services

Retail Trade

Commercial Services

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Finance

Finance

Health Technology

Finance

Health Technology

Technology Services

Vedi le connessioni aziendali